Medical Equipment & Supplies industry
24 companies · ₹27,892 cr · 5 with AI deep dives · Q1FY27 report
Revenue broad-based but margin split: shipping blockages and polymer inflation offset export recovery
- Revenue YoY
- +38.6%
- EBITDA margin
- 22.6%
- -350bps YoY
- Price, 1 year
- -29.9%
- 29% of names up
- P/E vs own 5y
- -25.7%
- 46.1x now
Exhibit 1The quarter in numbers
constant panel of 3 companies above ₹500 cr- Jun 26
- 718 cr
- Mar 26
- 753 cr
- QoQ
- -4.6%
- Jun 25
- 518 cr
- YoY
- +38.6%
- Peak
- 753 cr
- vs peak
- -4.6%
- Jun 26
- 22.6%
- Mar 26
- 19.3%
- QoQ
- +330bps
- Jun 25
- 26.1%
- YoY
- -350bps
- Peak
- 27.2%
- vs peak
- -460bps
Breadth: 100% of 5 companies grew revenue year on year (was 100% a quarter earlier) and 40% expanded margin (was 25%).
Exhibit 2What it costs
28.23x - 72.46x across the panel todayThe median name trades at 46.1x, -25.7% against this industry's own 5-year median of 62.0x, and -35.8% against its own peak of 71.8x.
Exhibit 3Structure
₹27,892 crPoly Medicure Ltd is 64.8% of this industry by market cap. The top 5 are 86.1% and the top 10 are 95.4%.
Exhibit 4Screen
P/E below the sub-industry median of 46.07x, 5y ROCE above its median of 12.26%, and at least 2 growth triggers stated on the latest earnings call.
Which names clear this screen is premium
The screen runs on stated growth triggers from the latest earnings calls - the same guidance data the stock screener reserves for premium. Premium names every company in this industry that is cheap against its own median and has the triggers behind it.
See plans →Exhibit 5Coverage (25 of 25)
Every company here with a deep dive, topped up by market cap. The rest of the industry is in the appendix.
- Mcap
- ₹2,358 cr
- P/E
- 78.3x
- EV/EBITDA
- 43.9x
- ROCE
- 12.7%
- Margin
- 15.1%
- Rev YoY
- +249.5%
- Mcap
- ₹683 cr
- P/E
- 37.6x
- EV/EBITDA
- 25.2x
- ROCE
- 19.5%
- Margin
- 12.2%
- Rev YoY
- +189.4%
- Mcap
- ₹216 cr
- P/E
- 17.9x
- EV/EBITDA
- 10.8x
- ROCE
- 18.9%
- Margin
- 15.5%
- Rev YoY
- +22.3%
- Mcap
- ₹168 cr
- P/E
- 20.4x
- EV/EBITDA
- 9.6x
- ROCE
- 12.5%
- Margin
- 16.3%
- Rev YoY
- +18.5%
Exhibit 6What managements said
from this industry's latest earnings calls · as of 2026-06-30Both POLYMED and FABTECH described identical structural blockage: containers unavailable, vessels not calling at ports. FABTECH quantified ₹20-22 Cr of finished goods at port at…
- POLYMED (Q1FY27): “shipping schedule is still disrupted for Middle East, and it's still hard to find…”
Exhibit 7Outlook
The outlook and what resolves next quarter
Where these managements said things are heading, and the dated, checkable events that would change it. Free with an account - 3 full reports a quarter.
Create a free account →